Home
About Us
Technology
Products
- Current Products
  - SENTIA
  - Xprecia Stride
- Laboratory Services
Investor Centre
Contact Us
Search

×

OTHER Latest News

UBI signs exclusive deal with Deakin and SwinburneApril 13, 2021
UBI signs global supply agreement for new technologyApril 09, 2021
UBI signs exclusive agreement for cancer biosensorApril 09, 2021
UBI signs Canadian distribution dealApril 02, 2021
Appendix 4E and Annual Report on Form 10-K FY2020February 25, 2021
The Future of UBIFebruary 10, 2021
UBI signs USA distribution dealJanuary 27, 2021
UBI's Canadian subsidiary signs deal with Bayer AGJanuary 05, 2021
UBI Signs Global Deal with LifeScanDecember 22, 2020
Australian Distributor Agreement for SentiaDecember 07, 2020

Investor Information

ASX Share Price
ASX Announcements
Download Annual Report
Hemostasis Reference Lab

2019 Annual Report 23 Mb PDF Document

February 25 2021

Appendix 4E and Annual Report on Form 10-K FY2020

Appendix 4E and Annual Report on Form 10-K FY2020

Stay informed on new products and news

Thank You for Subscribing with us

About Universal Biosensors

Universal Biosensors (UBI) began its journey focusing on the research, development and manufacture of devices for the diagnostic point of care (POC) market using UBI’s core technology of a disposable, multi-layer test strip, which incorporates a proprietary electrochemical sensing system that rapidly and accurately measures different biomarkers in blood.

Menu

Careers
Technology
Investor Centre

Products & Services

Current Products
Laboratory Services

Contact Us

Address: 1 Corporate Avenue, Rowville, Victoria, Australia 3178

Telephone: + 61 3 9213 9000

Email Address: info@universalbiosensors.com

Copyright 2020 Universal Biosensors | Privacy Policy | Web Terms & Conditions